TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
With over 9.3 million body shaping & skin tightening procedures performed in 2018 it is clear that patient demand for these types of treatments isn’t going anywhere. In fact by 2023 this number is estimated to grow by 30%1. By choosing the right professional cellulite treatment machine your practice can take advantage of this growing trend to improve patient satisfaction and ROI. Venus Legacy™ has been approved by the FDA for helping to temporarily reduce the appearance of cellulite.*
The highly advanced non-invasive medical device that effectively resolves challenging face and body aesthetic needs, such as non-surgical cellulite reduction and wrinkle reduction*. Treatments are comfortable with no downtime using RF technology that is safe for all skin types. Venus Legacy™ functions as a radio frequency machine for cellulite and is powered by proprietary (MP)2 technology (a combination of Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields) and features cutting-edge VariPulse™ technology.
Advanced technology and unique applicator design
Venus Legacy™ features four applicators: OctiPolar™ and 4D Body for larger areas, and DiamondPolar™ and 4D Face for smaller areas. All four applicators are powered by proprietary (MP)2 technology—only offered by Venus Concept’s cellulite removal devices—with the synergistic combination of Multi-Polar Radio Frequency (RF) and Pulsed Electro Magnetic Fields (PEMF). The OctiPolar™ and DiamondPolar™ applicators are indicated for wrinkle reduction treatments*, which leads to tightening of the skin. The 4D Body applicator is equipped with novel VariPulse™ technology, which makes it highly effective for cellulite reduction*.
![]() |
![]() |
![]() |
Venus Legacy™ includes various features that enable a higher return on ownership, such as affordable pricing, cutting-edge technology for all skin types, and no disposables. Venus Concept's industry-unique business model is designed to even further increase the success of your business.
Reduce bumps and dimpling around the buttocks and thighs, resulting in a smoother, slimmer silhouette.
Devices that offer cellulite reduction: Venus Legacy™
Results after: 8 treatments
Courtesy of View Laser, Martin Ray, MD
Reduce bumps and dimpling around the buttocks and thighs, resulting in a smoother, slimmer silhouette.
Devices that offer cellulite reduction: Venus Legacy™
Results after: 10 treatments
Courtesy of Synergy Aesthetics and Wellness
Reduce bumps and dimpling around the buttocks and thighs, resulting in a smoother, slimmer silhouette.
Devices that offer cellulite reduction: Venus Legacy™
Results after: 8 treatments
Courtesy of Venus Concept
Minimize the appearance of moderate to severe facial wrinkles and rhytides for noticeably more youthful-looking skin.
Devices that offer wrinkle reduction: Venus Freeze Plus™, Venus Legacy™, Venus Versa™
Results after: 10 treatments
Courtesy of Dolce Vida Medical Spa
INDICATIONS FOR USE:
*Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.↩
*Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.↩
REFERENCES:
1. Moretti, M. (2019, August). Medical Insight - Energy Based Body Shaping & Skin Tightening. [PDF]. California: Medical Insight Inc.
2. Callaghan, M. J., Chang, E. I., Seiser, N., Aarabi, S., Ghali, S., Kinnucan, E. R., . . . Gurtner, G. C. (2008). Pulsed Electromagnetic Fields Accelerate Normal and Diabetic Wound Healing by Increasing Endogenous FGF-2 Release. Plastic and Reconstructive Surgery, 121(1), 130-141. doi:10.1097/01.prs.0000293761.27219.84
To book a consultation or a demo, please contact us by clicking the button below and a representative will reach out to you directly.
For more information call: (888) 907-0115 // info@venusconcept.com // 1880 N Commerce Parkway, Suite 2, Weston, FL, 33326 United States
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite.
Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.
Venus Velocity™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae, for all Fitzpatrick skin types.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Freeze Plus™ is a non-invasive device cleared by the FDA for use in dermatologic and general surgical procedures for females for the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. The treatment of these conditions will lead to the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Epileve™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs
re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More